M&A Deal Summary

Gilde Healthcare Acquires Essange Reagents

On August 29, 2022, private equity firm Gilde Healthcare acquired life science company Essange Reagents from Sanquin Blood Supply Foundation

Acquisition Highlights
  • This is Gilde Healthcare’s 26th transaction in the Life Science sector.
  • This is Gilde Healthcare’s 20th transaction in the Netherlands.

M&A Deal Summary

Date 2022-08-29
Target Essange Reagents
Sector Life Science
Buyer(s) Gilde Healthcare
Sellers(s) Sanquin Blood Supply Foundation
Deal Type Divestiture

Target

Essange Reagents

Amsterdam, Netherlands
Essange Reagents is a producer in the field of hematology and immunology reagents, supplying tests to laboratories for medical diagnostics and research. Essange Reagents is based in Amsterdam, Netherlands.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Gilde Healthcare

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1982
PE ASSETS 2.6B EUR
Size Large
Type Sector Focused
DESCRIPTION

Gilde Healthcare is a specialist private equity and venture investor focused on the healthcare sector. The Firm's buyout group targets majority investments throughout Europe (preference for Germany, the Netherlands, Belgium, Austria or Switzerland) and has a focus on healthcare providers, suppliers and service providers active in the healthcare market. The Firm's venture group looks to invest in early stage medtech, diagnostics, digital health and therapeutics companies throughout North America and Europe. Gilde Healthcare was established in 1982 and is headquartered in Utrecht, Netherlands.


DEAL STATS #
Overall 53 of 55
Sector: Life Science M&A 26 of 26
Type: Divestiture M&A Deals 1 of 1
Country: Netherlands M&A 20 of 21
Year: 2022 M&A 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-05 Chr. Diener

Tuttlingen, Germany

Chr. Diener is an international contract manufacturer of customer-specific precision surgical instruments. The company builds on a long heritage of surgical instrument making. Today, the company has a good reputation for designing and manufacturing customer-specific instruments for several international Original Equipment Manufacturers in orthopedic- and spinal surgery. Through its state-of-the-art production technologies and comprehensive quality assurance system, Chr. Diener produces highly complex instruments complying with the most stringent quality standards. Chr. Diener was formed in 1900 and is based in Tuttlingen, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-15 Zetacom

Zoetermeer, Netherlands

Zetacomis is a systems integrator for critical communication systems and networking & security solutions. Zetacom provides communication solutions mainly to healthcare institutions, but also some selected government bodies, corporates and SMEs. Zetacom was founded in 2003 and is based in Zoetermeer, Netherlands.

Sell -

Seller(S) 1

SELLER

Sanquin Blood Supply Foundation

Amsterdam, Netherlands

Category Company
Founded 1998
Sector Life Science
DESCRIPTION

Sanquin Blood Supply Foundation provides blood services on a not-for-profit basis. Sanquin offers blood, and conducts scientific research in the fields of blood transfusion medicine and immunology, applying this knowledge to the development and production of a range of pharmaceutical and diagnostic services. Sanquin Blood Supply Foundation was founded in 1998 and is based in Amsterdam, Netherlands.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Divestiture M&A Deals 2 of 2
Country: Netherlands M&A 1 of 1
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-01 Prothya Biosolutions

Brussels, Belgium

Prothya Biosolutions produces and exports a broad range of pharmaceuticals for patients throughout the world. Prothya Biosolutions is based in Brussels, Belgium.

Sell -